ArticleBMC urology2025
The impact of chronic kidney disease stages and CROES AND GSS scores on stone free rate in kidney stones.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial intelligence-based prediction of stone-free status in patients undergoing mini-percutaneous nephrolithotomy without retrograde insertion of a ureteral catheter.World journal of urology · 2026Observational
- Unveiling potential natural promoters of calcium oxalate kidney stones in the urine via anion-exchange chromatography, crystal assays, and proteomics.Molecular and cellular biochemistry · 2026Article
- External Validation and Comparative Performance of the T.O.HO. and S.T.O.N.E. Scoring Systems for Predicting Stone-Free Outcomes Following Flexible Ureteroscopy: Toward Personalized Preoperative Counseling.Journal of personalized medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study evaluates the impact of chronic kidney disease (CKD) stages on stone-free rates (SFR) and renal function outcomes after percutaneous nephrolithotomy (PCNL). Additionally, it examines the predictive role of the CROES and Guy's Stone Score (GSS) systems.
methodsData from 2994 patients who underwent PCNL between 2007 and 2024 were retrospectively analyzed. Patients were classified into four CKD groups based on preoperative estimated glomerular filtration rate (eGFR). SFR, complication rates, and postoperative renal function changes were assessed.
resultsSFR was significantly lower in advanced CKD stages (p < 0.001), with the lowest in Group A (GFR < 30, 64.1%) and highest in Group D (GFR > 90, 79.1%). Postoperative eGFR increased in CKD stage 4-5 but declined in normal kidney function groups. Complication rates were higher in advanced CKD stages (p = 0.031). CROES and GSS scores correlated with stone complexity and surgical outcomes (p < 0.001).
conclusionAdvanced CKD is associated with lower SFR, greater surgical complexity, and higher complication rates. PCNL remains an effective treatment, particularly in CKD patients, with potential postoperative renal function improvement. Utilizing predictive scoring systems can optimize patient selection and surgical planning. Further prospective studies are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.